Grants awarded on behalf of ongoing commitment to spread awareness about organizations and individuals that are making a difference in the community
Submitted by Teva Pharmaceuticals
/PRNewswire/ - Teva Pharmaceuticals, in collaboration with the Philadelphia Eagles, today announced that it has awarded four grants totaling $125,000 to Philabundance, Students Run Philly Style, Twilight Wish Foundation and The Miracle League of Northampton Township, as part of the company's ongoing commitment to supporting local organizations in the Greater Philadelphia area.
These organizations are being awarded these grants in recognition of going above and beyond to advocate for the individual communities they serve, their alignment with Teva's values and culture, and the opportunity for employee involvement.
Following is information on the recipients and details on the specific grants:
"It is our privilege to work with these great organizations," said Denise Bradley, senior director corporate communications, Teva North America. "In conjunction with our partnership with the Eagles, we are able to provide support to those in the Greater Philadelphia Area who are making a difference in our community every day."
"Teva's desire to make a difference in the community is a part of its core mission. Our community partnership and the impact of making a positive difference will be felt for years to come," said Pamela Browner White, senior vice president of public affairs and government relations for the Philadelphia Eagles.
Teva Pharmaceuticals announced a five-year partnership with the Philadelphia Eagles at the start of the 2009 NFL season. Last year, the two organizations worked together on four projects, including Family Starting Line-Ups, the Community Red Zone, the Eagles Science Scholarship and the Eagles Community Quarterback Award. Eagles fans and Philadelphia natives can look forward to future community initiatives sponsored by Teva and the Eagles as part of their efforts to spread awareness about organizations and individuals that are making a difference in the community every day.
Philabundance is the region's largest hunger relief organization fighting hunger and malnutrition in the Delaware Valley. Philabundance provides a full plate of services to 500 member agencies in nine counties. Philabundance provides food to approximately 65,000 people per week, at an aggregate cost of less than 30 cents per meal. In 2009, Philabundance distributed 17 million pounds of food in the Delaware Valley. For more information about Philabundance, call 215-339-0900 or visit, www.philabundance.org.
About Students Run Philly Style
Since Students Run Philly Style's inception in 2004, the program has worked to improve the health and well-being of over 2,000 of Philadelphia's youth. Students Run Philly Style helps youth develop lifelong healthy behaviors, do better in school and make safe choices by partnering them with adult mentors who train with them for nine months to achieve the seemingly impossible goal of completing a marathon or half-marathon. Students train three to four times a week from March to November and complete eight public road races each season in addition to bi-weekly summer clinics, leadership development opportunities and academic enrichment opportunities. For more information about Students Run Philly Style, visit www.studentsrunphilly.org.
About Twilight Wish Foundation
Twilight Wish Foundation is a locally-headquartered national charitable organization that grants wishes to deserving, low-income elderly in the community. Since its founding in 2003, it has impacted the lives of more than 1,400 economically-disadvantaged seniors by providing what they could not provide for themselves. Twilight Wish enhances the quality of life for many vulnerable elderly by reducing isolation through items that increase mobility and accessibility, resulting in improved self-esteem and overall well-being. Its mission is to honor and enrich the lives of deserving elders through wish granting events connecting generations. The vision of Twilight Wish is to make our world a nicer place to age, one wish at a time. For more information about Twilight Wish Foundation, visit www.twilightwish.org.
About The Miracle League of Northampton
The Miracle League of Northampton is a baseball and softball league designed to accommodate children with special needs. The purpose of the league is to provide children with any physical or mental disability with the opportunity to play the great American game of baseball and/or other organized sports. There are currently 200 Miracle League Organizations across the country, including Puerto Rico - 100 completed rubberized fields and 100 fields under construction. The Miracle League proudly serves over 80,000 children and young adults with disabilities. For more information about The Miracle League of Northampton, visit http://www.miracleleaguenhpa1.org/.
Teva North America is a subsidiary of Teva Pharmaceuticals Ltd. In North America, Teva has locations in 10 states, Canada and Puerto Rico and more than 6,000 employees. In fact, one in every six prescriptions dispensed in the U.S. is a Teva product.
Teva Pharmaceutical Industries Ltd., headquartered in Israel, is a leading global pharmaceutical company, committed to providing consumers with access to high-quality healthcare by developing, producing and marketing affordable generic, innovative and specialty products, as well as active pharmaceutical ingredients.
The Company is the largest maker of generic pharmaceutical products, has a global product portfolio of more than 1,250 molecules and a direct presence in over 60 countries. The branded businesses focus on neurology, respiratory, women's health and biologics. www.tevapharm.com
Teva Pharmaceutical Industries Ltd. (NYSE and TASE:TEVA) is a leading global pharmaceutical company that delivers high-quality, patient-centric healthcare solutions to millions of patients every day. Headquartered in Israel, Teva is the world’s largest generic medicines producer, leveraging its portfolio of more than 1,000 molecules to produce a wide range of generic products in nearly every therapeutic area. In specialty medicines, Teva has a world-leading position in innovative treatments for disorders of the central nervous system, including pain, as well as a strong portfolio of respiratory products. Teva integrates its generics and specialty capabilities in its global research and development division to create new ways of addressing unmet patient needs by combining drug development capabilities with devices, services and technologies. Teva's net revenues in 2014 amounted to $20.3 billion. For more information, visit www.tevapharm.com.
More from Teva Pharmaceuticals